News

We invite you to learn about the positive impact we are having.

News Articles

Nic Dracopoli, Ph.D. Joins GenPro’s Scientific Advisory Board
January 9, 2020 0
GenPro to Present at Biotech Showcase™ Annual Conference on January 9, 2018
January 9, 2018 0
GenPro and Helen F. Graham Cancer Center Present A Novel Epigenetic Biomarker Discovery Approach to a Potential Prognostic Marker for Triple Negative Breast Cancer at NAACR Conference in Washington DC on April 1-4, 2017
April 4, 2017 0
GenPro presents azacitidine efficacy study to identify epigenetic predictors of Responder vs Non-Responder AML/MDS patients.
January 9, 2020 0
Genome Profiling’s CSO and Co-Founder, Dr. Adam Marsh, to Present at The Biomarker Conference in San Diego, February 18 – 19, 2016
February 19, 2016 0
Dr. Didier Landais joins Genome Profiling, LLC
January 9, 2020 0
Future for Epigenetic Breast Tumor Risk Screening
January 9, 2020

Citations

GenPro and Delaware’s Helen F. Graham Cancer Center Discover Novel EpiMarker
February 15, 2018 0
PharmaTech Outlook Selects GenPro to be among 2017’s Top 10
January 9, 2020 0
USA Today Reports on Christiana Care Collaboration with GenPro
October 9, 2017 0
GenPro publishes EpiMarker feasibility study revealing distinct epigenetic signature of Parkinson’s Disease in blood.
January 9, 2020 0
Biotech Firm May Change Cancer Treatment With Early Testing
July 19, 2015 0
Startup Genpro Aims To Use Epigenetic Analysis Tech For Biomarker Discovery, Test Development
July 9, 2015 0

Press Releases